Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.

Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases.

Saeki H, Tamaki K.

J Dermatol Sci. 2006 Aug;43(2):75-84. Epub 2006 Jul 21. Review.

PMID:
16859899
2.

IFN-gamma-inducible expression of thymus and activation-regulated chemokine/CCL17 and macrophage-derived chemokine/CCL22 in epidermal keratinocytes and their roles in atopic dermatitis.

Horikawa T, Nakayama T, Hikita I, Yamada H, Fujisawa R, Bito T, Harada S, Fukunaga A, Chantry D, Gray PW, Morita A, Suzuki R, Tezuka T, Ichihashi M, Yoshie O.

Int Immunol. 2002 Jul;14(7):767-73.

3.

Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides.

Kakinuma T, Sugaya M, Nakamura K, Kaneko F, Wakugawa M, Matsushima K, Tamaki K.

J Am Acad Dermatol. 2003 Jan;48(1):23-30.

PMID:
12522366
4.

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.

Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.

J Allergy Clin Immunol. 2001 Mar;107(3):535-41.

PMID:
11240957
5.

Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma.

Xiao T, Fujita H, Saeki H, Mitsui H, Sugaya M, Tada Y, Kakinuma T, Torii H, Nakamura K, Asahina A, Tamaki K.

Cytokine. 2003 Aug 21-Sep 7;23(4-5):126-32.

PMID:
12967648
6.

Differential regulation of thymus- and activation-regulated chemokine induced by IL-4, IL-13, TNF-alpha and IFN-gamma in human keratinocyte and fibroblast.

Yu B, Koga T, Urabe K, Moroi Y, Maeda S, Yanagihara Y, Furue M.

J Dermatol Sci. 2002 Oct;30(1):29-36.

PMID:
12354417
7.
8.
9.

High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.

Kakinuma T, Wakugawa M, Nakamura K, Hino H, Matsushima K, Tamaki K.

Br J Dermatol. 2003 Feb;148(2):203-10.

PMID:
12588369
10.

TGF-beta/Smad signaling inhibits IFN-gamma and TNF-alpha-induced TARC (CCL17) production in HaCaT cells.

Sumiyoshi K, Nakao A, Setoguchi Y, Tsuboi R, Okumura K, Ogawa H.

J Dermatol Sci. 2003 Feb;31(1):53-8.

PMID:
12615364
11.

TGF-beta1-mediated regulation of thymus and activation-regulated chemokine (TARC/CCL17) synthesis and secretion by HaCaT cells co-stimulated with TNF-alpha and IFN-gamma.

Zheng X, Nakamura K, Tojo M, Oyama N, Nishibu A, Satoh M, Kakinuma T, Wakugawa M, Tamaki K, Kaneko F.

J Dermatol Sci. 2002 Nov;30(2):154-60.

PMID:
12413771
12.

Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.

Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, Knol E.

J Allergy Clin Immunol. 2004 Feb;113(2):334-40.

PMID:
14767451
13.
14.

Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro.

Tsuda T, Tohyama M, Yamasaki K, Shirakata Y, Yahata Y, Tokumaru S, Sayama K, Hashimoto K.

J Dermatol Sci. 2003 Feb;31(1):37-42.

PMID:
12615362
15.

TARC augments TNF-alpha-induced CTACK production in keratinocytes.

Vestergaard C, Johansen C, Christensen U, Just H, Hohwy T, Deleuran M.

Exp Dermatol. 2004 Sep;13(9):551-7.

PMID:
15335355
16.

IL-10 augments the IFN-gamma and TNF-alpha induced TARC production in HaCaT cells: a possible mechanism in the inflammatory reaction of atopic dermatitis.

Vestergaard C, Kirstejn N, Gesser B, Mortensen JT, Matsushima K, Larsen CG.

J Dermatol Sci. 2001 May;26(1):46-54.

PMID:
11323220
17.

Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis.

Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chantry D, Suzuki R, Yoshie O.

J Allergy Clin Immunol. 2002 Jul;110(1):139-46.

PMID:
12110833
18.

Demonstration of TARC and CCR4 mRNA expression and distribution using in situ RT-PCR in the lesional skin of atopic dermatitis.

Zheng X, Nakamura K, Furukawa H, Nishibu A, Takahashi M, Tojo M, Kaneko F, Kakinuma T, Tamaki K.

J Dermatol. 2003 Jan;30(1):26-32.

PMID:
12598706
19.

Determination of thymus and activation-regulated chemokine (TARC)-contents in scales of atopic dermatitis.

Morita E, Hiragun T, Mihara S, Kaneko S, Matsuo H, Zhang Y, Dekio S.

J Dermatol Sci. 2004 May;34(3):237-40.

PMID:
15113595
20.

The adenylyl cyclase-cAMP system suppresses TARC/CCL17 and MDC/CCL22 production through p38 MAPK and NF-kappaB in HaCaT keratinocytes.

Qi XF, Kim DH, Yoon YS, Li JH, Song SB, Jin D, Huang XZ, Teng YC, Lee KJ.

Mol Immunol. 2009 Jun;46(10):1925-34. doi: 10.1016/j.molimm.2009.03.018. Epub 2009 Apr 16.

PMID:
19371952
Items per page

Supplemental Content

Write to the Help Desk